Technetium (99mTc) pintumomab
From Wikipedia, the free encyclopedia
- The correct title of this article is Technetium (99mTc) pintumomab. It features superscript or subscript characters that are substituted or omitted because of technical limitations.
|
Technetium (99mTc) pintumomab?
|
|
| Therapeutic monoclonal antibody | |
| Source | Mouse |
| Target | ? |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | ? |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Technetium (99mTc) pintumomab (INN) is a mouse monoclonal antibody used to treat cancer. Pintumomab has a radioisotope, technetium-99m.
|
||||||||||||||||||||||||||

